In the same meta-analysis, the risk of fibroid recurrence was found to be significantly higher following pretreatment with GnRH agonists compared to no pretreatment or placebo in laparoscopic myomectomy and the main reason accounting for this is likely the incomplete removal of fibroids owing to the loss of clear surgical planes [106]. The gene discussed is GNRH1; the disease is leiomyoma.